These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20980741)

  • 61. The immune system in hearing disorders.
    Veldman JE
    Acta Otolaryngol Suppl; 1988; 458():67-75. PubMed ID: 3072831
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autoimmunity and inner ear disorders: an immune-complex mediated sensorineural hearing loss.
    Veldman JE; Roord JJ; O'Connor AF; Shea JJ
    Laryngoscope; 1984 Apr; 94(4):501-7. PubMed ID: 6231440
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunobiology of the inner ear.
    Harris JP; Ryan AF
    Am J Otolaryngol; 1984; 5(6):418-25. PubMed ID: 6400717
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease.
    Saraçaydin A; Katircioglu S; Katircioglu S; Karatay MC
    J Int Med Res; 1993; 21(4):192-6. PubMed ID: 8112477
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acquired Glanzmann's thrombasthenia with optimal response to rituximab therapy.
    Solh M; Mescher C; Klappa A; Shah S; Zantek N; Datta Y
    Am J Hematol; 2011 Aug; 86(8):715-6. PubMed ID: 21761438
    [No Abstract]   [Full Text] [Related]  

  • 66. Review of the biologic agents used for immune-mediated inner ear disease.
    Lobo D; García-Berrocal JR; Trinidad A; Verdaguer JM; Ramírez-Camacho R
    Acta Otorrinolaringol Esp; 2013; 64(3):223-9. PubMed ID: 22770424
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune-mediated inner ear disorders: an otoimmunologist's view.
    Veldman JE
    Adv Otorhinolaryngol; 1991; 46():71-7. PubMed ID: 1927719
    [No Abstract]   [Full Text] [Related]  

  • 68. A complex case of anti-GAD antibody-related syndrome treated with Rituximab.
    Baroncini D; Spagnolo F; Sarro L; Comi G; Volonte' MA
    Neurol Sci; 2013 Oct; 34(10):1847-9. PubMed ID: 23404307
    [No Abstract]   [Full Text] [Related]  

  • 69. Autoimmune sensorineural hearing loss: an immunologic perspective.
    Solares CA; Hughes GB; Tuohy VK
    J Neuroimmunol; 2003 May; 138(1-2):1-7. PubMed ID: 12742646
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acquired haemophilia A treated with Rituximab in a patient with prostatic melioidosis.
    Kalro AK; Currie B; Szabo F
    Haemophilia; 2012 May; 18(3):e74-5. PubMed ID: 22531026
    [No Abstract]   [Full Text] [Related]  

  • 71. Autoimmune inner ear disease: results of therapy.
    McCabe BF
    Adv Otorhinolaryngol; 1991; 46():78-81. PubMed ID: 1927720
    [No Abstract]   [Full Text] [Related]  

  • 72. Clinical management of immune-mediated inner-ear disease.
    Rauch SD
    Ann N Y Acad Sci; 1997 Dec; 830():203-10. PubMed ID: 9616679
    [No Abstract]   [Full Text] [Related]  

  • 73. Immune-mediated cochleovestibular disease.
    Suchan M; Kaliarik L; Krempaska S; Koval J
    Bratisl Lek Listy; 2016; 117(2):87-90. PubMed ID: 26830038
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autoimmune inner ear disorders.
    Ryan AF; Keithley EM; Harris JP
    Curr Opin Neurol; 2001 Feb; 14(1):35-40. PubMed ID: 11176215
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Severe steroid-dependent idiopathic angioedema with response to rituximab.
    Ghazan-Shahi S; Ellis AK
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):374-6. PubMed ID: 21962102
    [No Abstract]   [Full Text] [Related]  

  • 76. Can sensitized lymphocytes retain reactivity to inner ear antigens after retrieval from frozen storage?
    Hughes GB; Paulic ZM; Shu S; Fairchild RL; Barna BP
    Laryngoscope; 1997 Jul; 107(7):878-82. PubMed ID: 9217123
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Primary intracranial plasma cell granuloma responsive to rituximab.
    Schneider C; Henning TD; Fink GR; Schroeter M; Lehmann HC
    Neurology; 2014 Sep; 83(12):1119-20. PubMed ID: 25107881
    [No Abstract]   [Full Text] [Related]  

  • 78. Correlation between antibodies to type II collagen and treatment outcome in bilateral progressive sensorineural hearing loss.
    Helfgott SM; Mosciscki RA; San Martin J; Lorenzo C; Kieval R; McKenna M; Nadol J; Trentham DE
    Lancet; 1991 Feb; 337(8738):387-9. PubMed ID: 1671423
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An open label study to evaluate the safety and efficacy of intratympanic golimumab therapy in patients with autoimmune inner ear disease.
    Derebery MJ; Fisher LM; Voelker CC; Calzada A
    Otol Neurotol; 2014 Oct; 35(9):1515-21. PubMed ID: 25203561
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predictive value of laboratory tests in "autoimmune" inner ear disease: preliminary report.
    Hughes GB; Barna BP; Kinney SE; Calabrese LH; Nalepa NL
    Laryngoscope; 1986 May; 96(5):502-5. PubMed ID: 3702564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.